Skip to main content
. 2020 Dec 1;31(1):17–24. doi: 10.1038/s41422-020-00450-0

Fig. 4. Dalbavancin inhibits SARS-CoV-2 replication and alleviates pneumonia in hACE2 mice.

Fig. 4

a hACE2 mice (n = 30) were infected with SARS-CoV-2 (100 μL by intranasally, 1 × 107 TCID50) and their lungs were harvested for viral load analysis at 1, 3, and 5 dpi, respectively (at 5 dpi, both saline and dalbavancin groups had no virus detected). b Histopathology of lungs from saline-treated and dalbavancin-treated mouse groups (5 dpi). c Effects of dalbavancin on body weight of hACE2 mice after SARA-CoV-2 infection. Means ± SD are shown. Statistical significance was measured by two-tail t-test compared with control group. *P < 0.05, **P < 0.01.